SightfileU.S. market data from official filings

Companies › NRIX

NURIX THERAPEUTICS INC (NRIX)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001549595 · EDGAR filings · Updated 2026-07-09

NURIX THERAPEUTICS INC (NRIX) has reported institutional ownership of 112.8%, with 196 institutional managers holding positions valued at $1.81B per the latest 13F reporting period. SEC filings include an active substantial-doubt (going concern) disclosure per the filings.

Institutional ownership
112.8%
Institutional managers
196
Reported 13F value
$1.81B
Insider activity
74 trans.
−$1.95M net selling
Data flags
1 active
from SEC filings

Latest updates

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, NURIX THERAPEUTICS INC has 196 institutional holders and institutional ownership of 112.8%.

Insider activity

Insiders reported 74 transactions (0 buys, 24 sells) across 4 reporting insiders, with a net reported value of −$1.95M.

Data flags from SEC filings

Active substantial-doubt (going concern) disclosure per the filings, most recently filed 2026-07-09 (recurring since 2024-02-15) — source filing. The authoritative details are those stated in the filing itself.

Related companies

TAKEDA PHARMACEUTICAL CO LTD (TAK) · GRAIL INC (GRAL) · SIONNA THERAPEUTICS INC (SION) · ADDUS HOMECARE CORP COM (ADUS) · ANI PHARMACEUTICALS INC (ANIP) · VERICEL CORP COM (VCEL)

See full history, cross-references and alerts on Sightfile
Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-09.